This study shows that two doses of a recombinant hepatitis B vaccine (
10 mu g or 20 mu g of HBsAg per dose), administered 6 months apart to
young, healthy adults, can induce an antibody (anti-HBs) response simi
lar to that expected with the standard three-dose regimen of this vacc
ine given at intervals of 0, 1 and 6 months. While only 46-67% of vacc
inees displayed a protective anti-HBs titer of greater than or equal t
o 10 mIU ml(-1) prior to the receipt of the second dose at 6 months, v
irtually all were primed as 97-99% of the subjects developed such a ti
ter when tested a month after the second dose. Among vaccinees given 1
0 or 20 mu g doses, respectively, the secondary rise in antibody follo
wing the second dose yielded geometric mean titers (GMTs) of 1103 and
2538 mIU ml(-1), respectively. The study further demonstrated that a t
wo-dose regimen of vaccination induced strong immunologic memory for H
BsAg, as a booster dose of vaccine given 2 years later resulted in a r
apid and vigorous anamnestic antibody response. (C) 1998 Elsevier Scie
nce Ltd. All rights reserved.